Home » Newsletters » BioWorld Science

BioWorld Science

July 14, 2016

View Archived Issues

Sapience completes series A financing

Inotek initiates phase II trial of trabodenoson/latanoprost FDC in glaucoma

Redx Pharma discovers novel bacterial topoisomerase inhibitors

Vaccine Technologies HIV vaccine LFn-p24B/C displays immunogenicity in phase I study

Redhill Biopharma signs collaboration agreement with NIAID

Faes Farma patents H1 receptor antagonists

Bioaffinity Technologies renews collaboration with University of Texas

Bristol-Myers Squibb discloses RIP-3 inhibitors

Muses Labs partners with Metabolon to apply metabolomics to Alzheimer's disease

Daiichi Sankyo develops retinoid RORgamma t antagonists and IL-17 production inhibitors

Boehringer Ingelheim and Eli Lilly collaborate on phase Ib trial for BI-836845

CytRx announces initial phase III results for aldoxorubicin in soft tissue sarcoma

Mologen enrolls first patient in phase I study for lefitolimod with ipilimumab

Novel macrolides show promise against macrolide-resistant Gram-positive isolates

FDA grants priority review to NDA for chewable tablet presentation of mebendazole

Scynexis sells cyclophilin inhibition assets to Cypralis

Invasive lobular breast carcinoma model created using CRISPR/Cas9 somatic gene editing

Avacta and Glythera collaborate to develop targeted biotherapeutics as alternative to ADCs

FDA grants breakthrough therapy designation to LOXO-101

MRIGlobal receives DTRA contract award to support development of tularemia vaccine

TARIS Biomedical starts phase Ib trial for TAR-200

Alere's rapid point-of-care fourth-generation HIV test receives WHO prequalification

Amgen and Daiichi Sankyo sign Japanese biosimilar commercialization agreement

Urolithin A improves muscle function; Amazentis conducts clinical trial

Evelo and Epiva merge to create immuno-microbiome company

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid
BioWorld
Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...